Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw
Sign Up to like & getrecommendations! Published in 2017 at "Osteoporosis International"
DOI: 10.1007/s00198-017-4343-2
Abstract: Although osteoradionecrosis (ORN) is a serious complication of craniofacial radiotherapy, the current management methods remain suboptimal. Teriparatide (TPTD), a recombinant human parathyroid hormone (1–34), has shown beneficial effects on osseous regeneration in medication-related osteonecrosis of… read more here.
Keywords: teriparatide therapy; tptd therapy; therapy; refractory ... See more keywords